Vaginal Bleeding in Late Trimester

  • Kiran Guleria
  • Bhanu Priya
  • Archana Chaudhary


Vaginal bleeding in late trimester constitutes some of the life-threatening complications for mother and neonate. Early recognition and effective management of the conditions—placenta previa, abruption placentae, and vasa previa—may reduce the maternal and perinatal mortality. Placenta previa is usually diagnosed before 20 weeks, but 90% resolves before 28 weeks. Persistent placenta previa in the third trimester mandates pelvic rest and hospitalization, if significant bleeding occurs. Placental abruption may require urgent termination of pregnancy to prevent maternal and fetal morbidity. Vasa previa is also a rare condition requiring urgent cesarean section to prevent fetal mortality. Significant vaginal bleeding from any cause is managed with rapid assessment of maternal and fetal status, fluid resuscitation, replacement of blood and blood products whenever necessary, and an appropriately timed delivery.


Vaginal bleeding Placenta previa Abruption placentae Vasa previa Maternal mortality 


  1. 1.
    Calleja-Agius J, Custo R, Brincat MP, Calleja N. Placental abruption and placenta praevia. Eur Clin Obstet Gynaecol. 2006;2:121–7.CrossRefGoogle Scholar
  2. 2.
    Bhide A, Prefumo F, Moore J, Hollis B, Thilaganathan B. Placental edge to internal os distance in the late third trimester and mode of delivery in placenta praevia. BJOG. 2003;110:860–4.CrossRefGoogle Scholar
  3. 3.
    Royal college of Obstetricians and Gynaecologists. Green Top Guidelines No 27: Placenta previa, Placenta previa accrete and Vasa previa: Diagnosis and Management. London: RCOG; 2011.Google Scholar
  4. 4.
    Silver RM, Landon MB, Rouse DJ, Leveno KJ, Spong CY, Thom EA, et al. National institute of child health and human development maternal-fetal medicine units network. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol. 2006;107:1226–32.CrossRefGoogle Scholar
  5. 5.
    Macafee CHG. Placenta praevia—a study of 174 cases. J Obstet Gynaecol Br Emp. 1945;52:313–24.CrossRefGoogle Scholar
  6. 6.
    Royal College of Obstetricians and Gynaecologists. Green top guidelines no 22: Rhesus D Prophylaxis, the use of anti-D Immunoglobulin for. London: RCOG; 2011.Google Scholar
  7. 7.
    Qureshi H, Massey E, Kirwan D, Davies T, Robson S, et al. BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn. Transfus Med. 2014;24(1):8–20.CrossRefGoogle Scholar
  8. 8.
    Sher G, Statland BE. Abruptio placentae with coagulopathy; a rational basis for management. Clin Obstet Gynecol. 1985;28(1):15–23.CrossRefGoogle Scholar
  9. 9.
    Towers CV, Pircon RA, Heppard M. Is tocolysis safe in the management of third-trimester bleeding? Am J Obstet Gynecol. 1999;180(6 pt 1):1572–8.CrossRefGoogle Scholar
  10. 10.
    Royal College of Obstetricians and Gynaecologists. Prevention and management of postpartum haemorrhage. In: Green-top Guideline No. 52. London: RCOG; 2009.Google Scholar
  11. 11.
    Oleyese KO, Turner M, Lees C, Campbell S. Vasa previa: an avoidable obstetric tragedy. Obstet Gynecol Surv. 1999;54:138–45.CrossRefGoogle Scholar
  12. 12.
    Stafford IP, Neumann DE, Jarrell H. Abnormal placental structure and vasa previa: confirmation of the relationship. J Ultrasound Med. 2004;23:1521–2.CrossRefGoogle Scholar
  13. 13.
    Oyalese KO, Turner M, Lees C, Campbell S. Vasa previa: an avoidable obstetric tragedy. Obstet Gynecol Surv. 1999;54:138–45.CrossRefGoogle Scholar
  14. 14.
    Zeltzer JS. Vaginal bleeding in late pregnancy. Chapter 254. In: Rakel RE, Bope ET, editors. Conn’s current therapy. 60th ed. Philadelphia: Saunders; 2008.Google Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  • Kiran Guleria
    • 1
  • Bhanu Priya
    • 1
  • Archana Chaudhary
    • 1
  1. 1.Department of Obstetrics & GynecologyUniversity College of medical Sciences & GTB HospitalDelhiIndia

Personalised recommendations